Velcade (Bortezomib) Consolidation After Transplant

NCT01539083 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

256

Enrollment

INDUSTRY

Sponsor class

Conditions

Multiple Myeloma

Interventions

DRUG: Thalidomide
DRUG: Bortezomib
DRUG: Cyclophosphamide
DRUG: Dexamethasone
DRUG: Prednisolone

Sponsor

Janssen Scientific Affairs, LLC